BMC PsychologyJanuary 2, 2026Reza Moshfeghinia, Sara Mostafavi, Kimia Jazi et al.2 citations
Psilocybin may reduce depressive symptoms in cancer patients, with mixed effects on anxiety and time-dependent improvements in spiritual well-being and (in single-arm data) quality of life. Given the small number of studies, high heterogeneity, challenges with blinding/expectancy, and frequent co-intervention with psychotherapy, these findings are preliminary. Larger, rigorously blinded trials...
TrialsApril 17, 2025Arash Mansoori, Amir Bazrafshan, Jamshid Ahmadi et al.4 citations
The concomitant presence of major depressive disorder (MDD) and opioid use disorder (OUD) poses a formidable clinical challenge, warranting effective interventions that address both psychiatric and addictive components. This study sought to compare the efficacy of adjunctive ketamine and buprenorphine in mitigating anxiety symptom severity and craving intensity in individuals with co-occurring...
Background: Cannabis use disorders and induced disorders are common in the world.Objective: To discuss an emergency psychotic patient having diagnosis of cannabis induced psychosis with severe use disorder who responded successfully to Electro Convulsive Therapy (ECT).Results: The patient improved after ECT administration.Discussion: This study clarified that ECT could be life saving in this...